This regime, therefore, specifically addresses the biochemical interactions during novel approaches that target the distinct membrane-associated redox system of bona fide tumor cells, which are characterized by the expression of membrane-associated catalase and NOX1 [30,31]. The gene discussed is NOX1; the disease is neoplasm.